World Investment Advisors Buys 3,803 Shares of Intuitive Surgical, Inc. $ISRG

World Investment Advisors increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 238.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,399 shares of the medical equipment provider’s stock after acquiring an additional 3,803 shares during the quarter. World Investment Advisors’ holdings in Intuitive Surgical were worth $2,415,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of Intuitive Surgical by 2.1% in the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after purchasing an additional 670,302 shares in the last quarter. State Street Corp lifted its stake in shares of Intuitive Surgical by 1.2% during the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after buying an additional 182,871 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Intuitive Surgical by 1.4% in the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock worth $4,429,590,000 after buying an additional 109,904 shares during the period. Norges Bank purchased a new stake in Intuitive Surgical in the 2nd quarter worth $2,569,260,000. Finally, Invesco Ltd. increased its stake in Intuitive Surgical by 4.8% in the 2nd quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock worth $2,402,488,000 after buying an additional 201,159 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 22,806 shares of the stock in a transaction on Monday, December 1st. The shares were sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the completion of the transaction, the insider owned 2,694 shares in the company, valued at $1,537,977.66. This trade represents a 89.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 104 shares of Intuitive Surgical stock in a transaction on Wednesday, December 10th. The stock was sold at an average price of $559.90, for a total transaction of $58,229.60. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 114,007 shares of company stock valued at $63,533,844 over the last quarter. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $577.81 on Friday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The business has a 50 day simple moving average of $555.54 and a two-hundred day simple moving average of $507.11. The stock has a market capitalization of $207.13 billion, a PE ratio of 76.43, a P/E/G ratio of 5.28 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the prior year, the firm earned $1.84 EPS. The company’s revenue for the quarter was up 22.9% on a year-over-year basis. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Leerink Partners boosted their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Mizuho set a $575.00 target price on Intuitive Surgical in a research note on Wednesday, October 22nd. Royal Bank Of Canada boosted their price target on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. The Goldman Sachs Group increased their price objective on shares of Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $611.08.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.